Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-12-003144)

Filing Details

Accession Number:: 0001181431-12-003144
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-19 16:14:22
Reporting Period:: 2012-01-17

Filing Date:: 2012-01-19
Accepted Time:: 2012-01-19 16:14:22
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1135906	Zalicus Inc.	ZLCS	Pharmaceutical Preparations (2834)	043514457

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1250661	Mark Corrigan	C/O Zalicus Inc. 245 First Street, 3Rd Floor Cambridge MA 02142	President & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2012-01-17	68,105	$1.14	706,940	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2010 and were to satisfy statutory tax withholding requirements upon vesting of restricted stock units.